Some insurers and TPAs do simply refuse to provide data, but, much more often, they will put up less obvious barriers, according to one House committee witness.
As medical and pharmacy expenses climb, large employers are adjusting plan design, limiting drug spending growth and expanding targeted support like caregiving and financial wellness benefits.
